Telomir Pharmaceuticals (Telomir Pharmaceuticals) Short-Term Debt : $0.00 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Telomir Pharmaceuticals Short-Term Debt?

Telomir Pharmaceuticals's Short-Term Debt for the quarter that ended in Mar. 2024 was $0.00 Mil.

Telomir Pharmaceuticals's quarterly Short-Term Debt declined from Sep. 2023 ($1.34 Mil) to Dec. 2023 ($0.10 Mil) and declined from Dec. 2023 ($0.10 Mil) to Mar. 2024 ($0.00 Mil).

Telomir Pharmaceuticals's annual Short-Term Debt stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.10 Mil).

Telomir Pharmaceuticals Short-Term Debt Historical Data

The historical data trend for Telomir Pharmaceuticals's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telomir Pharmaceuticals Short-Term Debt Chart

Telomir Pharmaceuticals Annual Data

Trend

Dec21

Dec22

Dec23

Short-Term Debt

0.10

Telomir Pharmaceuticals Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial				-	0.49	1.34	0.10	-

Telomir Pharmaceuticals Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Telomir Pharmaceuticals Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Telomir Pharmaceuticals's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telomir Pharmaceuticals Inc (NAS:TELO) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Headlines

From GuruFocus

UPDATE -- Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines

By GlobeNewswire • 03-29-2024